Victrex plc (LON:VCT) Receives GBX 720.83 Consensus Price Target from Analysts

Victrex plc (LON:VCT) has earned a consensus rating of “Hold” from the seven research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price target among brokers that have covered the stock in the last year is GBX 702.86.

Several research analysts recently issued reports on the stock. UBS Group reissued a “sell” rating and set a GBX 575 price target on shares of Victrex in a report on Monday, May 11th. JPMorgan Chase & Co. cut their price target on shares of Victrex from GBX 725 to GBX 625 and set a “buy” rating for the company in a report on Wednesday, March 18th. Canaccord Genuity Group cut shares of Victrex to a “buy” rating and set a GBX 725 price target for the company. in a report on Friday. Finally, Jefferies Financial Group cut their price target on shares of Victrex from GBX 675 to GBX 595 and set a “hold” rating for the company in a report on Tuesday.

Victrex Price Performance

Shares of VCT opened at GBX 581 on Monday. Victrex has a fifty-two week low of GBX 515 and a fifty-two week high of GBX 834. The company has a market capitalization of £506.19 million, a price-to-earnings ratio of 18.27, a price-to-earnings-growth ratio of 1.92 and a beta of 0.75. The firm has a 50-day simple moving average of GBX 600.81 and a 200-day simple moving average of GBX 641.91. The company has a debt-to-equity ratio of 21.30, a quick ratio of 1.99 and a current ratio of 2.35.

Victrex (LON:VCT) last announced its earnings results on Monday, May 11th. The company reported GBX 17.20 earnings per share for the quarter. The business had revenue of £147.10 million during the quarter. Victrex had a negative net margin of 6.70% and a negative return on equity of 4.95%. On average, equities research analysts anticipate that Victrex will post 73.1078905 earnings per share for the current year.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.